TD Cowen Raises GLP-1 Sales Forecast to $150 Billion

TD Cowen has significantly increased its sales forecast for GLP-1 drugs, now projecting them to reach $150 billion. This revised outlook underscores the growing market potential and demand for this class of pharmaceuticals.